Projects per year
Personal profile
Courses
Biopharmaceutical Testing Operations
Cancer Biology and Cancer Therapy
Biopharmaceutical Testing
Biotechnology Industrial Analysis and Corporate Valuation
Microbiology
Seminar
Education
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Keywords
- Anti-viral drug development
- Cancer biology
- Microbiology
- Mitosis
- Molecular Cell Biology
- Molecular viology
- Protein Biochemistry
- Yeast Molecular Genetics
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 4 Finished
-
Role of Nuclear Egfr in Dna Repair and Chemoresistance
Hsu, S.-C. (PI)
01/08/12 → 31/07/13
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Role of Nuclear EGFR in DNA Repair and Chemoresistance
Hsu, S.-C. (PI)
01/08/11 → 31/07/12
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Role of Nuclear eGFR in DNA Repair and Chemoresistance
Hsu, S.-C. (PI)
01/08/10 → 31/07/11
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Exploration of the Biological Functionality of EGFR in the Nucleus
Hsu, S.-C. (PI)
01/08/09 → 31/07/10
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Laminin Receptor-Mediated Nanoparticle Uptake by Tumor Cells: Interplay of Epigallocatechin Gallate and Magnetic Force at Nano–Bio Interface
Hsu, S. C., Wu, N. P., Lu, Y. C. & Ma, Y. H., 08 2022, In: Pharmaceutics. 14, 8, 1523.Research output: Contribution to journal › Journal Article › peer-review
Open Access5 Scopus citations -
Small molecule chemosensitizing agents: polo-like kinase 1 (Plk1), BRAF and janus kinase (JAK) inhibitors.
Wu, C.-P. & Hsu, S.-C., 2019, Protein Kinase Inhibitors As Sensitizing Agents for Chemotherapy.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents
Hsiao, S. H., Lusvarghi, S., Huang, Y. H., Ambudkar, S. V., Hsu, S. C. & Wu, C. P., 31 03 2019, In: Cancer Letters. 445, p. 34-44 11 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access29 Scopus citations -
Optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells from Col1a1 4F2A-Oct4-GFP mice with high efficiency
Lin, P. Y., Hsu, S. C., Chen, H. C., Len, W. B., Hsiao, F. C., Liu, M. C., Pan, P. L., Lin, T. C., Lee, Y. H. & Meir, Y. J. J., 05 2018, In: FEBS Journal. 285, 9, p. 1667-1683 17 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access4 Scopus citations -
Resveratrol mitigates high-fat diet-induced vascular dysfunction by activating the Akt/eNOS/NO and Sirt1/ER pathway
Huang, J. P., Hsu, S. C., Li, D. E., Chen, K. H., Kuo, C. Y. & Hung, L. M., 2018, In: Journal of Cardiovascular Pharmacology. 72, 5, p. 231-241 11 p.Research output: Contribution to journal › Journal Article › peer-review
26 Scopus citations
Prizes
-
2023 Distinguished Teaching Award-Guidance Award (Mentor)
Hsu, S.-C. (Recipient), 2023
Prize: Distinguished Faculty Award › Distinguished Faculty Award-Guidance Award (Mentor)